Plain-English translation of NCT07267793 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing CartiPRO, a collagen-based injection designed to help rebuild damaged cartilage and reduce knee pain in people with osteoarthritis. The medication works differently than other common knee injections because collagen has a stronger, longer-lasting structure. Researchers want to understand how safe and effective repeated doses of this treatment are over the long term.
Osteoarthritis is one of the most common joint problems, especially in people over 60, and it causes progressive cartilage damage that leads to chronic pain and stiffness. While this medication shows promise because it targets the root cause (collagen breakdown) rather than just masking symptoms, there is limited long-term safety and effectiveness data from repeated use—which this study aims to provide.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic several times over about 6 months or longer. At your first visit, you will receive an injection of either CartiPRO or a control treatment (Synovian) directly into your knee joint. You will return for follow-up visits at 2 weeks, 4 weeks, 12 weeks, and beyond to report your pain levels and answer questions about how your knee is feeling. At 24 weeks, you may receive a second injection. Throughout the study, doctors will monitor you for any side effects and ask you to track your pain using simple rating scales.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
South Korea